Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

NCT03424603 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Lymphoma
Non Hodgkin Lymphoma
Multiple Myeloma
Follicular Lymphoma
Mantle Cell Lymphoma
Diffuse Large B Cell Lymphoma
Indolent Lymphoma
B Cells--Tumors

Interventions

DRUG: STRO-001

Sponsor

Sutro Biopharma, Inc.